From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialty Care>
  3. Oncology and Hematology>
  4. About>
  5. Disclosure Information

Disclosure Information

The editors of Journal Watch Oncology and Hematology have disclosed the following information in keeping with the conflict of interest policy of the MMS Professional Newsletters:

William J. Gradishar, MD, Editor-in-Chief
Consultant / Advisory board
  • Abraxis BioScience Inc.; AstraZeneca; Bristol-Myers Squibb; Genentech; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; sanofi-aventis
Speaker's bureau
  • Abraxis BioSciene Inc.; AstraZeneca; Bristol-Myers Squibb; Genentech; Genomic Health; Novartis; Pfizer
Grant / research support
  • Various clinical trials
Editorial boards
  • Clinical Breast Cancer; Oncology
Leadership positions in professional societies
  • American College of Surgeons Commission on Cancer (Executive Committee); Association of Subspecialty Professors (Board Member)
Robert Dreicer, MD, MS, FACP, Associate Editor
Consultant / Advisory board
  • Bristol-Myers Squibb; Eli Lilly; MedImmune; Merck; Pfizer
Speaker's bureau
  • Berlex; sanofi-aventis
Grant / research support
  • American BioScience; Berlex; Celgene; Eli Lilly
Editorial boards
  • Journal of Clinical Oncology; Journal of Supportive Oncology
David Green, MD, PhD, Associate Editor
Nothing to disclose
  •  
David H. Ilson, MD, PhD, Associate Editor
Speaker's bureau
  • Amgen; Genentech; Inclone; Pfizer; sanofi-aventis
Grant / research support
  • Bristol-Myers Squibb; Genentech; sanofi-aventis
Henry Mark Kuerer, MD, PhD, FACS, Associate Editor
Speaker's bureau
  • Physician Education Resource
Grant / research support
  • Genentec
Editorial boards
  • Annals of Surgical Oncology; Breast Disease Quarterly; Cancer Journal; Journal of Clinical Oncology
Leadership positions in professional societies
  • Society of Surgical Oncology (Program Chair)
Barbara A. Murphy, MD, Associate Editor
Consultant / Advisory board
  • Bristol-Myers Squibb; MedImmune
Speaker's bureau
  • Amgen; Bristol-Myers Squibb
Grant / research support
  • MedImmune
Editorial boards
  • Journal of Supportive Oncology
Leadership positions in professional societies
  • Eastern Cooperative Oncology Group (Chair for Head and Neck Cancer)
Michael E. Williams, MD, Associate Editor
Consultant / Advisory board
  • Celgene
Speaker's bureau
  • Biogen IDEC; Educational Concepts Group; Genentech; Health Science Communications
Grant / research support
  • Lymphoma Research Foundation; Cephalon; Genentech
Editorial boards
  • Modern Pathology; The Hematologist
Leadership positions in professional societies
  • American Society of Hematology (Chair, Educational Affairs Committee); Lymphoma Research Foundation (Chair, Mantle Cell Lymphoma Consortium and Member, Scientific Advisory Board)

Editors who have left the board since January 2007

Manuel Hidalgo, MD, PhD, Associate Editor 2006-2008
Consultant / Advisory board
  • Amgen; AstraZeneca
Grant / research support
  • AstraZeneca; EISAI; RayBiotech; Wyeth
Editorial boards
  • Molecular Cancer Therapeutics

This information reflects Dr. Hidalgo's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2008.

Mark A. Socinski, MD, Associate Editor 2006–2007
Consultant / Advisory board
  • Genentech; Eli Lilly
Speaker's bureau
  • Amgen; Genentech; Eli Lilly; sanofi-aventis
Grant / research support
  • Genentech; Eli Lilly; Pfizer; sanofi-aventis
Editorial boards
  • Journal of Clinical Oncology

This information reflects Dr. Socinski's annual report of disclosable interests at the time he was last affiliated with Journal Watch, in 2007.

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.